Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01274416 · ClinicalTrials.gov registry record · NA

Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT01274416 is a NA study that has completed, run by Duke University. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01274416, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The investigators are trying to learn the most effective way to treat an adolescent's eating disorder and how best to involve the parents or caregivers in this process. Typically, parents and their child are seen together in therapy. However, this can sometimes be difficult for both the parents and the adolescent. Both parents and adolescents have different concerns and are struggling with different aspects of the eating disorder. Therefore, the treatment in this study involves the parents in treatment, but does not have therapy sessions with the parents and child together. The purpose of this study is to develop this investigational type of treatment (separated family treatment), and see what works best for adolescents and their families. Participants meet with a therapist for 20 sessions over the course of 24 weeks. For the first 16 weeks families separate therapy sessions weekly. For the last 8 weeks families meet with the therapist bi-weekly. These bi-weekly sessions are conjoint - that is, adolescents and parents will meet with the therapist together. This is to help parents and adolescents come together as a family to continue to aid the adolescent in the treatment of his/her eating disorder. The investigators hypothesize that adolescents who receive ASFT will demonstrate improvement in eating disorder symptoms and body-mass index, that caregivers who participate in ASFT will demonstrate decreased distress and caregiver burden, that increases in psychological acceptance will be seen for both adolescents and caregivers post-treatment, and that treatment will be viewed as both credible and acceptable to both caregiver and adolescent

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy
  • BEHAVIORAL Parent Skills Training

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2009-05
Est. Completion 2012-05
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01274416

The ClinicalTrials.gov registry entry for NCT01274416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.

NCT01274416 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01274416 about?

NCT01274416 is a clinical study titled "Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa". The investigators are trying to learn the most effective way to treat an adolescent's eating disorder and how best to involve the parents or caregivers in this process. Typically, parents and their child are seen together in therapy. However, this can sometimes be difficult for both the parents and...

What is the current status of trial NCT01274416?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2009-05. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01274416?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Parent Skills Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01274416?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.